serogroup B meningococcal vaccine (Bexsero) Report issue

Active Ingredient History

  • Now
Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
menb | menbvac | recombinant neisseria meningitidis group-b nhba fusion protein /recombinant neisseria meningitidis group-b nada protein /recombinant neisseria meningitidis group b fhbp fusion protein /outer membrane vesiclesfrom neisseria meningitidis group-b strain nz98 / 254 measured as amount of total protein containing the pora p1.4 | rmenb


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue